|
2025-02-21 |
2025-02-18 |
S
Sale
|
York Charles N II
COO, CFO AND SECRETARY
Officer
|
4,370
-1.7%
11.96
USD 52,278
|
4,370
-1.7%
|
11.96
|
USD 52,278
|
|
|
2025-02-21 |
2025-02-18 |
S
Sale
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Executive Director
|
12,048
-8.6%
11.96
USD 144,130
|
12,048
-8.6%
|
11.96
|
USD 144,130
|
|
|
2025-02-21 |
2025-02-18 |
S
Sale
|
Dubow Adam
GENERAL COUNSEL
Officer
|
4,646
-10.5%
11.96
USD 55,580
|
4,646
-10.5%
|
11.96
|
USD 55,580
|
|
|
2024-12-12 |
2024-12-10 |
PS
Planned sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
30,000
-2.8%
13.31
USD 399,339
|
30,000
-2.8%
|
13.31
|
USD 399,339
|
|
|
2024-11-19 |
2024-11-18 |
S
Sale
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Executive Director
|
10,554
-8.9%
13.21
USD 139,420
|
10,554
-8.9%
|
13.21
|
USD 139,420
|
|
|
2024-11-19 |
2024-11-18 |
S
Sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
2,206
-0.2%
13.21
USD 29,142
|
2,206
-0.2%
|
13.21
|
USD 29,142
|
|
|
2024-11-19 |
2024-11-18 |
S
Sale
|
York Charles N II
COO, CFO AND SECRETARY
Officer
|
2,602
-1.1%
13.21
USD 34,373
|
2,602
-1.1%
|
13.21
|
USD 34,373
|
|
|
2024-11-19 |
2024-11-18 |
S
Sale
|
Dubow Adam
GENERAL COUNSEL
Officer
|
3,165
-9.0%
13.21
USD 41,810
|
3,165
-9.0%
|
13.21
|
USD 41,810
|
|
|
2024-11-12 |
2024-11-11 |
PS
Planned sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
10,000
-0.9%
16.10
USD 160,994
|
10,000
-0.9%
|
16.10
|
USD 160,994
|
|
|
2024-11-12 |
2024-11-08 |
PS
Planned sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
18,255
-1.7%
16.17
USD 295,229
|
18,255
-1.7%
|
16.17
|
USD 295,229
|
|
|
2024-11-08 |
2024-11-07 |
PS
Planned sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
11,245
-1.0%
16.03
USD 180,287
|
11,245
-1.0%
|
16.03
|
USD 180,287
|
|
|
2024-11-04 |
2024-10-31 |
PS
Planned sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
500
-0.0%
16.02
USD 8,010
|
500
-0.0%
|
16.02
|
USD 8,010
|
|
|
2024-09-12 |
2024-09-10 |
PS
Planned sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
30,000
-2.7%
14.22
USD 426,675
|
30,000
-2.7%
|
14.22
|
USD 426,675
|
|
|
2024-08-19 |
2024-08-16 |
S
Sale
|
York Charles N II
COO, CFO AND SECRETARY
Officer
|
2,633
-1.1%
14.00
USD 36,860
|
2,633
-1.1%
|
14.00
|
USD 36,860
|
|
|
2024-08-19 |
2024-08-16 |
S
Sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
2,232
-0.2%
14.00
USD 31,246
|
2,232
-0.2%
|
14.00
|
USD 31,246
|
|
|
2024-08-19 |
2024-08-16 |
S
Sale
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Executive Director
|
10,681
-9.7%
14.00
USD 149,524
|
10,681
-9.7%
|
14.00
|
USD 149,524
|
|
|
2024-08-19 |
2024-08-16 |
S
Sale
|
Dubow Adam
GENERAL COUNSEL
Officer
|
3,202
-10.6%
14.00
USD 44,825
|
3,202
-10.6%
|
14.00
|
USD 44,825
|
|
|
2024-07-17 |
2024-07-16 |
PS
Planned sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
20,000
-1.8%
16.01
USD 320,226
|
20,000
-1.8%
|
16.01
|
USD 320,226
|
|
|
2024-06-21 |
2024-06-21 |
S
Sale
|
Ramasastry Saira
Non-Executive Director
|
10,000
-19.8%
13.19
USD 131,877
|
10,000
-19.8%
|
13.19
|
USD 131,877
|
|
|
2024-06-12 |
2024-06-10 |
PS
Planned sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
30,000
-2.6%
12.62
USD 378,588
|
30,000
-2.6%
|
12.62
|
USD 378,588
|
|
|
2024-05-17 |
2024-05-16 |
S
Sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
2,267
-0.2%
16.08
USD 36,450
|
2,267
-0.2%
|
16.08
|
USD 36,450
|
|
|
2024-05-17 |
2024-05-16 |
S
Sale
|
York Charles N II
COO, CFO AND SECRETARY
Officer
|
2,675
-1.2%
16.08
USD 43,011
|
2,675
-1.2%
|
16.08
|
USD 43,011
|
|
|
2024-05-17 |
2024-05-16 |
S
Sale
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Executive Director
|
7,873
-1.2%
16.08
USD 126,588
|
7,873
-1.2%
|
16.08
|
USD 126,588
|
|
|
2024-05-17 |
2024-05-16 |
S
Sale
|
Dubow Adam
GENERAL COUNSEL
Officer
|
3,253
-13.0%
16.08
USD 52,304
|
3,253
-13.0%
|
16.08
|
USD 52,304
|
|
|
2024-05-14 |
2024-05-10 |
PS
Planned sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
10,000
-0.9%
16.37
USD 163,743
|
10,000
-0.9%
|
16.37
|
USD 163,743
|
|
|
2024-05-03 |
2024-05-03 |
PS
Planned sale
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Executive Director
|
9,154
-1.4%
17.85
USD 163,417
|
9,154
-1.4%
|
17.85
|
USD 163,417
|
|
|
2024-05-03 |
2024-05-03 |
PS
Planned sale
|
York Charles N II
COO, CFO AND SECRETARY
Officer
|
8,078
-3.6%
17.85
USD 144,214
|
8,078
-3.6%
|
17.85
|
USD 144,214
|
|
|
2024-05-03 |
2024-05-02 |
PS
Planned sale
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Executive Director
|
6
-0.0%
17.94
USD 108
|
6
-0.0%
|
17.94
|
USD 108
|
|
|
2024-05-03 |
2024-05-02 |
PS
Planned sale
|
York Charles N II
COO, CFO AND SECRETARY
Officer
|
200
-0.1%
17.90
USD 3,579
|
200
-0.1%
|
17.90
|
USD 3,579
|
|
|
2024-05-03 |
2024-05-01 |
PS
Planned sale
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Executive Director
|
70,051
-9.7%
17.88
USD 1,252,183
|
70,051
-9.7%
|
17.88
|
USD 1,252,183
|
|
|
2024-05-03 |
2024-05-01 |
PS
Planned sale
|
York Charles N II
COO, CFO AND SECRETARY
Officer
|
52,183
-18.8%
17.89
USD 933,397
|
52,183
-18.8%
|
17.89
|
USD 933,397
|
|
|
2024-04-22 |
2024-04-18 |
PS
Planned sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
10,000
-0.8%
16.02
USD 160,163
|
10,000
-0.8%
|
16.02
|
USD 160,163
|
|
|
2024-03-26 |
2024-03-25 |
PS
Planned sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
10,000
-0.8%
16.01
USD 160,055
|
10,000
-0.8%
|
16.01
|
USD 160,055
|
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
30,000
-2.4%
15.24
USD 457,314
|
30,000
-2.4%
|
15.24
|
USD 457,314
|
|
|
2024-02-28 |
2024-02-27 |
PS
Planned sale
|
Blackman Samuel C.
HEAD OF R&D
Officer
|
20,000
-1.6%
16.11
USD 322,166
|
20,000
-1.6%
|
16.11
|
USD 322,166
|
|
|
2024-02-20 |
2024-02-16 |
S
Sale
|
Blackman Samuel C.
HEAD OF RESEARCH AND DEVELOPME
Officer
|
2,258
-0.2%
15.25
USD 34,430
|
2,258
-0.2%
|
15.25
|
USD 34,430
|
|
|
2024-02-20 |
2024-02-16 |
S
Sale
|
Dubow Adam
GENERAL COUNSEL
Officer
|
3,242
-16.4%
15.25
USD 49,434
|
3,242
-16.4%
|
15.25
|
USD 49,434
|
|
|
2024-02-20 |
2024-02-16 |
S
Sale
|
York Charles N II
COO, CFO AND SECRETARY
Officer
|
2,666
-1.0%
15.25
USD 40,651
|
2,666
-1.0%
|
15.25
|
USD 40,651
|
|
|
2024-02-20 |
2024-02-16 |
S
Sale
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Executive Director
|
7,615
-1.0%
15.25
USD 116,114
|
7,615
-1.0%
|
15.25
|
USD 116,114
|
|
|
2023-11-17 |
2023-11-16 |
S
Sale
|
Dubow Adam
General Counsel
Officer
|
5,313
-31.7%
11.69
USD 62,109
|
5,313
-31.7%
|
11.69
|
USD 62,109
|
|
|
2023-11-17 |
2023-11-16 |
S
Sale
|
Blackman Samuel C.
Head of Research and Developme
Officer
|
709
-0.1%
11.69
USD 8,288
|
709
-0.1%
|
11.69
|
USD 8,288
|
|
|
2023-11-17 |
2023-11-16 |
S
Sale
|
Bender Jeremy
Chief Executive Officer
Executive Director
|
3,107
-0.4%
11.69
USD 36,321
|
3,107
-0.4%
|
11.69
|
USD 36,321
|
|
|
2023-11-17 |
2023-11-16 |
S
Sale
|
York Charles N II
COO, CFO and Secretary
Officer
|
956
-0.4%
11.69
USD 11,176
|
956
-0.4%
|
11.69
|
USD 11,176
|
|
|
2023-10-20 |
2023-10-20 |
B
Purchase
|
AI Day1 LLC
Affiliate of 10% Owner
Large shareholder
|
111,387
+0.9%
9.97
USD 1,110,907
|
111,387
+0.9%
|
9.97
|
USD 1,110,907
|
|
|
2023-10-20 |
2023-10-19 |
B
Purchase
|
AI Day1 LLC
Affiliate of 10% Owner
Large shareholder
|
384,400
+3.1%
10.06
USD 3,867,372
|
384,400
+3.1%
|
10.06
|
USD 3,867,372
|
|
|
2023-10-20 |
2023-10-18 |
B
Purchase
|
AI Day1 LLC
Affiliate of 10% Owner
Large shareholder
|
979,667
+8.6%
10.21
USD 10,000,049
|
979,667
+8.6%
|
10.21
|
USD 10,000,049
|
|
|
2023-08-17 |
2023-08-17 |
S
Sale
|
Blackman Samuel C.
Head of Research and Developme
Officer
|
668
-0.1%
13.86
USD 9,258
|
668
-0.1%
|
13.86
|
USD 9,258
|
|
|
2023-08-17 |
2023-08-17 |
S
Sale
|
Bender Jeremy
Chief Executive Officer
Executive Director
|
2,996
-0.4%
13.86
USD 41,525
|
2,996
-0.4%
|
13.86
|
USD 41,525
|
|
|
2023-08-17 |
2023-08-17 |
S
Sale
|
York Charles N II
COO, CFO and Secretary
Officer
|
922
-0.3%
13.86
USD 12,779
|
922
-0.3%
|
13.86
|
USD 12,779
|
|
|
2023-06-12 |
2023-06-09 |
B
Purchase
|
AI Day1 LLC
Affiliate of 10% Owner
Large shareholder
|
769,230
+7.2%
13.00
USD 9,999,990
|
769,230
+7.2%
|
13.00
|
USD 9,999,990
|
|
|
2023-06-07 |
2023-06-05 |
PS
Planned sale
|
Blackman Samuel C.
Chief Medical Officer
Officer
|
1,229
-0.1%
16.00
USD 19,664
|
1,229
-0.1%
|
16.00
|
USD 19,664
|
|
|
2023-05-17 |
2023-05-16 |
S
Sale
|
Bender Jeremy
Chief Executive Officer
Executive Director
|
3,104
-0.3%
13.12
USD 40,732
|
3,104
-0.3%
|
13.12
|
USD 40,732
|
|
|
2023-05-17 |
2023-05-16 |
S
Sale
|
Blackman Samuel C.
Chief Medical Officer
Officer
|
692
-0.1%
13.12
USD 9,081
|
692
-0.1%
|
13.12
|
USD 9,081
|
|
|
2023-05-17 |
2023-05-16 |
S
Sale
|
York Charles N II
COO, CFO and Secretary
Officer
|
955
-0.4%
13.12
USD 12,532
|
955
-0.4%
|
13.12
|
USD 12,532
|
|
|
2023-03-14 |
2023-03-10 |
PS
Planned sale
|
Blackman Samuel C.
Chief Medical Officer
Officer
|
10,000
-0.8%
18.05
USD 180,484
|
10,000
-0.8%
|
18.05
|
USD 180,484
|
|
|
2023-03-08 |
2023-03-07 |
PS
Planned sale
|
Bender Jeremy
Chief Executive Officer
Executive Director
|
12,500
-1.1%
20.01
USD 250,114
|
12,500
-1.1%
|
20.01
|
USD 250,114
|
|
|
2023-03-03 |
2023-03-01 |
PS
Planned sale
|
Grant Julie Papanek
Non-Executive Director
|
25,000
-7.0%
18.61
USD 465,303
|
25,000
-7.0%
|
18.61
|
USD 465,303
|
|
|
2023-02-21 |
2023-02-17 |
PS
Planned sale
|
York Charles N II
COO, CFO and Secretary
Officer
|
9,377
-3.5%
20.03
USD 187,790
|
9,377
-3.5%
|
20.03
|
USD 187,790
|
|
|
2023-02-17 |
2023-02-16 |
S
Sale
|
Bender Jeremy
Chief Executive Officer
Executive Director
|
3,022
-0.3%
19.57
USD 59,150
|
3,022
-0.3%
|
19.57
|
USD 59,150
|
|
|
2023-02-17 |
2023-02-16 |
S
Sale
|
York Charles N II
COO, CFO and Secretary
Officer
|
930
-0.3%
19.57
USD 18,203
|
930
-0.3%
|
19.57
|
USD 18,203
|
|
|
2023-02-17 |
2023-02-16 |
S
Sale
|
Blackman Samuel C.
Chief Medical Officer
Officer
|
674
-0.1%
19.57
USD 13,192
|
674
-0.1%
|
19.57
|
USD 13,192
|
|
|
2023-02-13 |
2023-02-10 |
PS
Planned sale
|
Blackman Samuel C.
Chief Medical Officer
Officer
|
10,000
-0.8%
20.07
USD 200,659
|
10,000
-0.8%
|
20.07
|
USD 200,659
|
|
|
2023-02-03 |
2023-02-01 |
PS
Planned sale
|
Grant Julie Papanek
Non-Executive Director
|
1,106
-0.3%
21.69
USD 23,988
|
1,106
-0.3%
|
21.69
|
USD 23,988
|
|
|
2023-02-03 |
2023-02-01 |
PS
Planned sale
|
Grant Julie Papanek
Non-Executive Director
|
23,894
-6.3%
21.21
USD 506,806
|
23,894
-6.3%
|
21.21
|
USD 506,806
|
|
|
2023-01-24 |
2023-01-23 |
PS
Planned sale
|
Bender Jeremy
Chief Executive Officer
Executive Director
|
12,500
-1.0%
22.00
USD 274,988
|
12,500
-1.0%
|
22.00
|
USD 274,988
|
|
|
2023-01-23 |
2023-01-20 |
PS
Planned sale
|
York Charles N II
COO, CFO and Secretary
Officer
|
10,000
-3.6%
22.75
USD 227,523
|
10,000
-3.6%
|
22.75
|
USD 227,523
|
|
|
2023-01-11 |
2023-01-10 |
PS
Planned sale
|
Blackman Samuel C.
Chief Medical Officer
Officer
|
2,500
-0.2%
23.20
USD 58,011
|
2,500
-0.2%
|
23.20
|
USD 58,011
|
|
|
2023-01-11 |
2023-01-10 |
PS
Planned sale
|
Blackman Samuel C.
Chief Medical Officer
Officer
|
7,500
-0.6%
22.75
USD 170,633
|
7,500
-0.6%
|
22.75
|
USD 170,633
|
|
|
2023-01-04 |
2023-01-03 |
PS
Planned sale
|
Grant Julie Papanek
Non-Executive Director
|
7,610
-2.0%
21.31
USD 162,174
|
7,610
-2.0%
|
21.31
|
USD 162,174
|
|
|
2023-01-04 |
2023-01-03 |
PS
Planned sale
|
Grant Julie Papanek
Non-Executive Director
|
17,390
-4.3%
20.36
USD 353,973
|
17,390
-4.3%
|
20.36
|
USD 353,973
|
|
|
2022-12-22 |
2022-12-21 |
PS
Planned sale
|
Bender Jeremy
Chief Executive Officer
Executive Director
|
12,500
-1.0%
20.32
USD 253,969
|
12,500
-1.0%
|
20.32
|
USD 253,969
|
|
|
2022-12-22 |
2022-12-20 |
PS
Planned sale
|
York Charles N II
COO, CFO and Secretary
Officer
|
10,000
-3.5%
20.07
USD 200,650
|
10,000
-3.5%
|
20.07
|
USD 200,650
|
|
|
2022-12-12 |
2022-12-08 |
PS
Planned sale
|
Grant Julie Papanek
Non-Executive Director
|
4,358
-1.1%
22.08
USD 96,210
|
4,358
-1.1%
|
22.08
|
USD 96,210
|
|
|
2022-12-05 |
2022-12-02 |
PS
Planned sale
|
Grant Julie Papanek
Non-Executive Director
|
5,000
-1.2%
21.55
USD 107,726
|
5,000
-1.2%
|
21.55
|
USD 107,726
|
|
|
2022-12-05 |
2022-12-01 |
PS
Planned sale
|
Blackman Samuel C.
Chief Medical Officer
Officer
|
900
-0.1%
22.16
USD 19,940
|
900
-0.1%
|
22.16
|
USD 19,940
|
|
